EMBioSys
PrivateLast Round
Grant
Nov 25, 2025
Total Funding Raised
$1.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EMBioSys is a medical technology company that develops non-invasive, wearable garments using induced electric field (iEF) therapy to treat aggressive cancers like triple-negative breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EMBioSys Comparables
Compare EMBioSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novocure | 71% | |
| QV Bioelectronics | 61% | |
| INIA Biosciences | 57% | |
EMBioSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 25, 2025 | ||||
| Seed | Apr 30, 2025 | ||||
| Grant | May 9, 2024 |
EMBioSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Received $1.38M from National Cancer Institute and NIH RADx.
- Apr 30, 2025
Raised $3M in a seed funding round.
EMBioSys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EMBioSys's valuation, stock price, and market status.